YFY Biotech Management Company focuses on investing in biotechnology companies, primarily in Taiwan. The firm specializes in later-stage investments, with a particular emphasis on Series C funding rounds. Their investment strategy targets promising biotech ventures that have demonstrated significant progress and potential for growth.

The company's portfolio includes notable investments such as Elixir Pharmaceuticals, which has raised a total of $31 million. YFY Biotech Management Company aims to support and accelerate the development of innovative biotechnology solutions, contributing to advancements in the healthcare and life sciences sectors in Taiwan and beyond.